Crispr Therapeutics AG (NASDAQ:CRSP) Director Pablo J. Cagnoni Sells 7,500 Shares

 

Crispr Therapeutics AG (NASDAQ:CRSP) Director Pablo J. Cagnoni Sells 7,500 Shares

See Also: FAANG Stocks Receive News & Ratings for Crispr Therapeutics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Crispr …

More Crispr Therapeutics AG (NASDAQ:CRSP) Director Pablo J. Cagnoni Sells 7,500 Shares Videos

Leave a Reply